Abstract:To evaluate the therapeutic effect of autologous transplantation of Schwann cells as "bridge" between the medial forebrain bundle (MFB) and caudate nucleus, into the brain of hemiparkinsonian monkey.Six monkeys were used following 6-OHDA-induced hemiparkinsonism. Three of them were autologous transplanted using Schwann cells as "bridges" between MFB and caudate nucleus. The Schwann cells were pre-treated using Hoechst33342. The other three monkeys received sham operation as controls. All the monkeys received behavioral assessment. The metabolism of dopamine was measured by SPECT using (99)Tcm-TRODAT-1 and PET using 18F-FP-beta-CIT. After a 4-month follow-up, the monkeys' brain were removed from the skull, fixed in 4% paraformaldehyde and cut into serial sections. A fluorescence microscope examination and a tyroxine hydroxylase (TH) immunohistochemistry study were made on the sections. Cell types were determined by double staining. The level of TH protein around the needle track was determined by Western blotting.All three monkeys, which had undergone Schwann cells autologous bridge graft showed a decrease in the disability score and two of them had an increase in motor activity. The apomorphine evoked rotation was also decreased. The symptoms of the monkeys, which received sham operation, had not amelioration. In SPECT examination, the radioactivity count was greatly increased in the grafted monkeys. The dopamine levels were significantly increased in the caudate nucleus from 61% (before graft) to 79% (after graft) while there's no change in control group. In histological examination, autologous Schwann cells could survive and migrate in the brain. Around the Schwann cells "bridge", there were numerous TH positive short fibers in the MFB area. Around the whole length of the "bridge", there were a lot of TH positive reactive astrocytes, especially in thalamus. TH protein around the needle track of the graft group was 243% compared with that of control group.Autologous Schwann cells bridge graft is a feasible technique with therapeutic effects on parkinson disease monkeys. The Schwann cells play an important role in dopaminergic axonal elongation and in inducing the TH positive phenotype of reactive astroglia cell around it.

Primary experimental study on the triple transduction of dopamine biosynthetic enzyme genes in monkeys with Parkinson's disease

Long-term Behavioral Recovery in Parkinsonian Rats by Triple Transduction with Dopamine-Biosynthesizing Enzyme Genes

An Accelerated Parkinson’s Disease Monkey Model Using AAV-α-synuclein Plus Poly(adp-Ribose)

Adeno-Associated Virus Vector-Mediated Triple Gene Transfer Of Dopamine Synthetic Enzymes

An adeno-associated virus vector-mediated multiple gene transfer for dopamine synthetic enzymes

Genetically engineered mesenchymal stem cells with dopamine synthesis for Parkinson's disease in animal models

1-Methyl-4-phenylpyridinium Stereotactic Infusion Completely and Specifically Ablated the Nigrostriatal Dopaminergic Pathway in Rhesus Macaque.

Observation on intracerebrally transplanted BMSCs-D-NSCs modified by TH and EGFP gene in hemiparkinsonism monkey

The Therapeutic Effect of Intracerebral Transplantation of SPIO and EGFP Double Labeled GDNF Gene Modified Mesencephalic Neural Stem Cells in Rat Model of Parkinson's Disease

Bone marrow stromal cell transplantation for treatment of Parkinson's disease in rhesus monkeys

Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model

Cotransduction Of Tyrosine Hydroxylase And Aromatic L-Amino Acid Decarboxylase Genes Into Cultured Striatal Cells Using Adeno-Associated Virus Vectors

The Temporary and Accumulated Effects of Transcranial Direct Current Stimulation for the Treatment of Advanced Parkinson'S Disease Monkeys

A quantitative approach to developing Parkinsonian monkeys (Macaca fascicularis) with intracerebroventricular 1-methyl-4-phenylpyridinium injections

Autologous Transplant Therapy Alleviates Motor and Depressive Behaviors in Parkinsonian Monkeys.

Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease

Differentiation of Adult Human Retinal Pigment Epithelial Cells into Dopaminergic-Like Cells in Vitro and in the Recipient Monkey Brain

Adenovirus-Mediated Th Gene Therapy of Parkinson's Disease in Experimental Rat Model

In vivo Neuroregeneration to Treat Ischemic Stroke Through NeuroD1 AAV-Based Gene Therapy in Adult Non-human Primates

Therapeutic study of autologous Schwann cells' bridge graft into the brain of hemiparkinsonian monkey]

An accelerated Parkinson's disease monkey model using AAV-α-synuclein plus poly(ADP-ribose)